Cerebrospinal fluid biomarkers of Alzheimer’s disease

CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease

(2013) Jon B. Toledo et al.   ACTA NEUROPATHOLOGICA

BACE1 Levels Correlate with Phospho-Tau Levels in Human Cerebrospinal Fluid

(2013) Soraia Barao et al.   Current Alzheimer Research

Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer’s disease

(2013) Liang-Hao Guo et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia

(2012) Mirko Bibl et al.   JOURNAL OF NEURAL TRANSMISSION

Neurotoxicity and Memory Deficits Induced by Soluble Low-Molecular-Weight Amyloid- 1-42 Oligomers Are Revealed In Vivo by Using a Novel Animal Model

(2012) J. Brouillette et al.   JOURNAL OF NEUROSCIENCE

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

(2012) Thorlakur Jonsson et al.   NATURE

CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease

(2012) R. Tarawneh et al.   NEUROLOGY

Biomarkers in Alzheimer's disease drug development

(2011) Jeffrey L. Cummings   Alzheimers & Dementia

Visinin-like protein-1: Diagnostic and prognostic biomarker in Alzheimer disease

(2011) Rawan Tarawneh et al.   ANNALS OF NEUROLOGY

Chemokines in CSF of Alzheimer's disease patients

(2011) Jôice Dias Corrêa et al.   ARQUIVOS DE NEURO-PSIQUIATRIA

Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer’s disease and other dementias

(2011) Jean-Daniel Abraham et al.   BIOMARKERS

Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease

(2011) Hong Jiang et al.   Molecular Neurodegeneration

Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease

(2011) Richard J. Perrin et al.   PLoS One

Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis

(2011) Rebecca Craig-Schapiro et al.   PLoS One

Peptide Fingerprinting of Alzheimer's Disease in Cerebrospinal Fluid: Identification and Prospective Evaluation of New Synaptic Biomarkers

(2011) Holger Jahn et al.   PLoS One

Bioluminescence imaging of A  deposition in bigenic mouse models of Alzheimer's disease

(2011) J. C. Watts et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Proteomic technologies for the identification of disease biomarkers in serum: Advances and challenges ahead

(2011) Sandipan Ray et al.   PROTEOMICS

Nano-HPLC–MS analysis of phospholipids in cerebrospinal fluid of Alzheimer’s disease patients—a pilot study

(2010) M. Kosicek et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease

(2010) Rebecca Craig-Schapiro et al.   BIOLOGICAL PSYCHIATRY

Macrophage Colony-Stimulating Factor (M-CSF) in Plasma and CSF of Patients with Mild Cognitive Impairment and Alzheimers Disease

(2010) C. Laske et al.   Current Alzheimer Research

Increased Levels of Soluble LR11 in Cerebrospinal Fluid of Patients with Alzheimer Disease

(2010) Takeshi Ikeuchi et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects

(2010) Liana G. Apostolova et al.   NEUROBIOLOGY OF AGING

Increased Cerebrospinal Fluid F2-Isoprostanes are Associated with Aging and Latent Alzheimer’s Disease as Identified by Biomarkers

(2010) Thomas J. Montine et al.   NEUROMOLECULAR MEDICINE

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY

Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases

(2009) Guo Nan Yin et al.   BRAIN RESEARCH

Amyloid- (1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease

(2009) C. Mulder et al.   CLINICAL CHEMISTRY

CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

(2009) Niklas Mattsson   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Dkk-3 is elevated in CSF and plasma of Alzheimer’s disease patients

(2009) Christoph Zenzmaier et al.   JOURNAL OF NEUROCHEMISTRY

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

(2009) Richard J. Perrin et al.   NATURE

S100A7, a Novel Alzheimer's Disease Biomarker with Non-Amyloidogenic α-Secretase Activity Acts via Selective Promotion of ADAM-10

(2009) Weiping Qin et al.   PLoS One

Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

(2008) Clive Holmes et al.   LANCET

Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia

(2007) Sebastiaan Engelborghs et al.   NEUROBIOLOGY OF AGING

Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment

(2007) Miroslaw Brys et al.   NEUROBIOLOGY OF AGING